Eprosartan (formerly SKF-108566J; SKF108566; SKF 108566; Teveten; Futuran; Navixen; Regulaten) is a nonpeptide angiotensin II receptor antagonist that has been approved as an antihypertensive medication for the treatment of high blood pressure. It inhibits angiotensin II receptor with an IC50 of 9.2 and 3.9 nM in rat and human adrenal cortical membranes, respectively.

纯度：≥98%

CAS：133040-01-4